Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

aristo pharma gmbh - lacosamide - lacosamide

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

s.f. group s.r.l. - lacosamide - lacosamide

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

teva b.v. - lacosamide - lacosamide

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

hameln pharma gmbh - lacosamide - lacosamide

Kesatuan Eropah - Itali - EMA (European Medicines Agency)

extrovis eu ltd. - lacosamide - epilessia - antiepilettici, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

tecnigen s.r.l. - lacosamide - lacosamide

Itali - Itali - AIFA (Agenzia Italiana del Farmaco)

vivanta generics s.r.o. - lacosamide - lacosamide